These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 27559030

  • 1. Clinical and Laboratory Evaluation of a New Specific Point-of-Care Test for Intact Proinsulin.
    Pfützner A, Pfützner AH, Kann PH, Burgard G.
    J Diabetes Sci Technol; 2017 Mar; 11(2):278-283. PubMed ID: 27559030
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Increased Intact Proinsulin in the Oral Glucose Challenge Sample is an Early Indicator for Future Type 2 Diabetes Development - Case Reports and Evidence from the Literature.
    Pfützner A, Manessis A, Hanna MR, Lewin J.
    Clin Lab; 2020 May 01; 66(5):. PubMed ID: 32390400
    [Abstract] [Full Text] [Related]

  • 5. Clinical and laboratory evaluation of specific chemiluminescence assays for intact and total proinsulin.
    Pfützner A, Kunt T, Langenfeld M, Löbig M, Knesovic M, Forst T.
    Clin Chem Lab Med; 2003 Sep 01; 41(9):1234-8. PubMed ID: 14598875
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes.
    Pfützner A, Kunt T, Hohberg C, Mondok A, Pahler S, Konrad T, Lübben G, Forst T.
    Diabetes Care; 2004 Mar 01; 27(3):682-7. PubMed ID: 14988285
    [Abstract] [Full Text] [Related]

  • 8. Immunoradiometric assay of human intact proinsulin applied to patients with type 2 diabetes, impaired glucose tolerance, and hyperandrogenism.
    Chevenne D, Ruiz J, Lohmann L, Laudat A, Leblanc H, Gray IP, Passa P, Porquet D.
    Clin Chem; 1994 May 01; 40(5):754-7. PubMed ID: 8174247
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of linagliptin compared with glimepiride on postprandial glucose metabolism, islet cell function and vascular function parameters in patients with type 2 diabetes mellitus receiving ongoing metformin treatment.
    Forst T, Anastassiadis E, Diessel S, Löffler A, Pfützner A.
    Diabetes Metab Res Rev; 2014 Oct 01; 30(7):582-9. PubMed ID: 24459063
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevalence-dependent decision limits for the early detection of type 2 diabetes mellitus in venous blood, venous plasma and capillary blood during glucose challenge.
    Haeckel R, Raber R, Wosniok W.
    Clin Chem Lab Med; 2006 Oct 01; 44(12):1462-71. PubMed ID: 17163824
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological PPARgamma stimulation in contrast to beta cell stimulation results in an improvement in adiponectin and proinsulin intact levels and reduces intima media thickness in patients with type 2 diabetes.
    Forst T, Hohberg C, Fuellert SD, Lübben G, Konrad T, Löbig M, Weber MM, Sachara C, Gottschall V, Pfützner A.
    Horm Metab Res; 2005 Aug 01; 37(8):521-7. PubMed ID: 16138267
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Performance of Point-of-Care Testing Compared with the Standard Laboratory Diagnostic Test in the Measurement of HbA1c in Indonesian Diabetic and Nondiabetic Subjects.
    Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R.
    J Diabetes Res; 2020 Aug 01; 2020():2037565. PubMed ID: 32733964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.